Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
Abstract ATTR amyloidosis is caused by systemic deposition of transthyretin (TTR) and comprises ATTRwt (wt for wild-type) amyloidosis, ATTRv (v for variant) amyloidosis, and acquired ATTR amyloidosis after domino liver transplantation. ATTRwt amyloidosis has classically been regarded as cardiomyopat...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Adis, Springer Healthcare
2020-09-01
|
| Series: | Neurology and Therapy |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s40120-020-00210-7 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
